Advertisement
Research report| Volume 117, ISSUE 1, P61-71, September 1995

Download started.

Ok

Evaluation of oxidative stress in patients with hyperlipidemia

  • Fernanda B. Araujo
    Affiliations
    Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences (FCFUSP), University of São Paulo, Av. Prof. Lineu Prestes, 580, Cidade Universitária C.P. 66083, CEP 05389-970, São Paulo, Brazil
    Search for articles by this author
  • Décio S. Barbosa
    Affiliations
    Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences (FCFUSP), University of São Paulo, Av. Prof. Lineu Prestes, 580, Cidade Universitária C.P. 66083, CEP 05389-970, São Paulo, Brazil
    Search for articles by this author
  • Chang Y. Hsin
    Affiliations
    Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences (FCFUSP), University of São Paulo, Av. Prof. Lineu Prestes, 580, Cidade Universitária C.P. 66083, CEP 05389-970, São Paulo, Brazil
    Search for articles by this author
  • Raul C. Maranhão
    Affiliations
    Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences (FCFUSP), University of São Paulo, Av. Prof. Lineu Prestes, 580, Cidade Universitária C.P. 66083, CEP 05389-970, São Paulo, Brazil

    Heart Institute (Instituto do Coração HC-FMUSP), University of São Paulo, Av. Prof. Lineu Prestes, 580, Cidade Universitária C.P. 66083, CEP 05389-970, São Paulo, Brazil
    Search for articles by this author
  • Dulcineia S.P. Abdalla
    Correspondence
    Corresponding author. Fax: +55 11 813 2197.
    Affiliations
    Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences (FCFUSP), University of São Paulo, Av. Prof. Lineu Prestes, 580, Cidade Universitária C.P. 66083, CEP 05389-970, São Paulo, Brazil
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      An antioxidant defense system consisting of enzymes and non-enzymatic compounds prevents oxidative damage of lipoproteins in the plasma. When the activity of this system decreases or the reactive oxygen species (ROS) production increases, an oxidative stress may occur. Since fatty acids and triglyceride-rich emulsions can stimulate leukocytes to produce ROS, it is conceivable that raised plasma triglyceride-rich lipoproteins such as very low density lipoprotein (VLDL) may overload the antioxidant system. To test this hypothesis, we selected 14 patients with combined hyperlipidemia (HLP), in whom low density lipoprotein (LDL) and VLDL levels are elevated, as well as 18 hypercholesterolemic patients (HCH) with increased LDL levels and 19 controls (NL) to examine the trend for an imbalance between the production of oxidative species and the antioxidant defense system as challenged by increased plasma lipids. With this goal, plasma lipoprotein lipid fractions were determined and correlated with the release of ROS by leukocytes monitored by luminol-enhanced chemiluminescence. Plasma β-carotene, α-tocopherol, lycopene and the lipoprotein lipid hydroperoxides were determined by high pressure liquid chromatography with electrochemical detection. HLP had lower plasma superoxide dismutase (SOD) activity (0.04 and 0.11 U/mg protein; P < 0.05) as well as lower concentrations of lycopene (0.1 and 0.2 nmol/mg cholesterol; P < 0.05) and β-carotene (0.8 and 2.7 nmol/mg cholesterol; P < 0.05) in the plasma, as compared with NL. Moreover, HLP showed the highest ROS production by resting mononuclear leukocytes (MN) among the three study groups. When the results of the subjects of the three groups were taken together, the plasma triglyceride concentration was positively correlated to ROS release by resting polymorphonuclear leukocytes (PMN, r = 0.38, P = 0.04) and MN (r = 0.56, P < 0.005). Moreover, ROS release by resting MN was positively correlated with VLDL (r = 0.47, P = 0.02) and LDL (r = 0.57, P =0.01) triglycerides. There was also a positive correlation between ROS release by stimulated PMN and VLDL (r = 0.44, P = 0.03) as well as LDL (r = 0.53, P = 0.01) triglycerides. High density lipoprotein (HDL) cholesterol showed a negative correlation with ROS release by resting MN (r = −0.48, P = 0.02) and resting PMN (r = −0.49, P = 0.01). VLDL susceptibility to copper (II) oxidation was not different among the three groups. Regarding LDL, there was an increased oxidizability in HLP group. Plasma ferritin, which may act as a source of catalytic iron for lipid peroxidation, was found to be greater in HLP and HCH than in controls (P < 0.05). These results suggest that oxidative stress is more likely to occur in HLP than in NL and HCH, since in HLP the release of ROS by leukocytes was greater, while some components of their antioxidant defense system were also decreased. Our finding that the leukocyte ROS production is positively correlated with either VLDL or LDL triglycerides sheds light on a new aspect of the leukocyte activation and oxidative stress in hyperlipidemia.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Halliwell B
        • Gutteridge JMC
        The importance of free radicals and catalytic metal ions in human diseases.
        Molec Aspects Med. 1985; 8: 89
        • Hiramatsu K
        • Rosen H
        • Heinecke JW
        • Wolfbauer G
        • Chait A
        Superoxide initiates oxidation of low density lipoprotein by human monocytes.
        Arteriosclerosis. 1987; 7: 55
        • Cathcart M.K.
        • Morel D.V.
        • Chilsolm G.M.
        Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic.
        J Leukocyte Biol. 1985; 38: 341
        • Abdalla D.S.P.
        • Campa A
        • Monteiro HP
        Low density lipoprotein oxidation by stimulated neutrophils and ferritin.
        Atherosclerosis. 1992; 97: 149
        • Lunec J
        Oxygen radicals: their measurement and role in major diseases.
        J Int Fed Clin Chem. 1992; 4: 58
        • Parthasarathy S
        • Rankin SM
        Role of oxidized low density lipoprotein in atherogenesis.
        Prog Lipid Res. 1992; 31: 127
        • Boyum A
        Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one g centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g.
        Scand J Lab Invest. 1968; 21: 77
        • Oyanagui Y
        Reevaluation of assay methods and establishment of kit for superoxide dismutase activity.
        Anal Biochem. 1984; 142: 290
        • Sinet P.M.
        • Michelson A.M.
        • Bazin A
        • Lejecine J
        • Jerome H
        Increase in glutathione peroxidase activity in erythrocytes from trisomy 21 subjects.
        Biochem Biophys Res Commun. 1975; 67: 910
        • Thurnan D.I.
        • Smith E
        • Flora P.S.
        Concurrent liquid-chromatographic assay of retinol, α-tocopherol, β-carotene, α-carotene, lycopene and β-cryptoxanthin.
        Clin Chem. 1988; 34: 337
        • Redgrave T.G.
        • Roberts D.C.K.
        • West C.E.
        Separation of plasma lipoprotein by density-gradient ultracentrifugation.
        Anal Biochem. 1975; 65: 42
        • Terao J
        • Shibata S.S.
        • Matsushita S
        Selective quantification of arachidonic acid hydroperoxides and their hydroxy derivatives in reverse-phase high performance liquid chromatography.
        Anal Biochem. 1988; 169: 415
        • Sas Institute Inc
        4th edn. Sas/STAT User's Guide. Sas Institute Inc, Cary, NC1989 (version 6)
        • Rosner B
        Fundamentals of Biostatistics.
        2nd edn. Duxbury Press, Boston, MA1986
        • Hiramatsu K
        • Arimori S
        Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes.
        Diabetes. 1988; 37: 832
        • Prónai L
        • Hiramatsu K
        • Saigusa Y
        • Nakazawa H
        Low superoxide scavenging activity associated with enhanced superoxide generation by monocytes from male hypertriglyceridemia with and without diabetes.
        Atherosclerosis. 1991; 90: 49
        • Ludwig P.W.
        • Hunninghake D.B.
        • Hoidal J.R.
        Increased leukocyte oxidative metabolism in hyperlipoproteinemia.
        Lancet. 1982; 2: 348
        • Krause S
        • Pohl C
        • Liebrenz A
        • Ruhling K
        • Lösche W
        Increased generation of reactive oxygen species in monuclear blood cells from hypercholesterolemic patients.
        Thromb Res. 1993; 71: 237
        • Badwey J.A.
        • Curnutte J.T.
        • Karnovsky M.L.
        cis-polyunsaturated fatty acids induce high levels of superoxide production by human neutrophils.
        J Biol Chem. 1981; 256: 12 640
        • Ozawa M
        • Ohtsuka T
        • Okamura N
        • Ishibashi S
        Synergism between protein kinase C activator and fatty acids in stimulating superoxide anion production in guinea pig polymorphonuclear leukocytes.
        Arch Biochem Biophys. 1989; 273: 491
        • Kakinuma K
        Effects of fatty acids on the oxidative metabolism of leukocytes.
        Biochim Biophys Acta. 1974; 348: 76
        • Morel F
        • Doussiere J
        • Vignais PV
        The superoxide-generating oxidase of phagocytic cells. Physiological, molecular and pathological aspects.
        J Biochem. 1991; 201: 523
        • Henderson LM
        • Moule S.K.
        • Chappell JB
        The immediate activator of the NADPH oxidase is arachidonate not phosphorylation.
        Eur J Biochem. 1993; 211: 157
        • Görög P
        Activation of human blood monocytes by oxidized polyunsaturated faty acids: a possible mechanism for the generation of lipid peroxides in the circulation.
        Int J Exp Pathol. 1991; 72: 227
        • Bellinati-Pires R
        • Waitzberg D.L.
        • Salgado M.M.
        • Carneiro-Sampaio M.M.S.
        Functional alterations of human neutrophils by medium chain tryglyceride emulsions: evaluation of phagocythosis, bacterial killing, and oxidative activity.
        J Leukocyte Biol. 1993; 53: 404
        • Biemond P.E.
        • Van Eijik H.G.
        • Swaak A.J.
        • Koster J.F.
        Iron mobilization from ferritin by superoxide derived from stimulated polumorphonuclear leukocytes: possible mechanism in inflammatory diseases.
        J Clin Invest. 1984; 73: 1576
        • Salonen J.T.
        • Nyyssönen K
        • Korpela H
        • Tuomiletho J
        • Seppänen R
        • Salonen R
        High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men.
        Circulation. 1992; 86: 803
        • Kuijk F.J.G.M.
        • Sevanian A
        • Handelman G.J.
        • Dratz E.A.
        A new role for phospholipase A2: protection of membranes from lipid peroxidation damage.
        TIBS. 1987; 12: 31
        • Assmann G
        • Schulte H
        Role of triglycerides in coronary artery disease: lessons from the prospective cardiovascular Munster study.
        Am J Cardiol. 1992; 70: 10H
        • Gotto A.M.
        Hypertriglyceridemia: risks and perspectives.
        Am J Cardiol. 1992; 70: 19H
        • Hodis H.N.
        • Mack W.J.
        • Azen S.P.
        • Alaupovic P
        • Pogoda JM
        • LaBree L
        • Hemphill LC
        • Kramsch Blankenhorn DH
        Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.
        Circulation. 1994; 90: 42
        • Cathcart MK
        • Morel DW
        • Chisolm GM
        Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic.
        J Leukocyte Biol. 1985; 38: 341
        • Korpela H
        Increased myocardial and hepatic iron concentration in pigs with microangiopathy (Mulberry heart disease) as a risk factor of oxidative damage.
        Ann Nutr Metab. 1990; 34: 193
        • Goldstein JL
        • Brow MS
        The low density lipoprotein pathway and its relation to atherosclerosis.
        Annu Rev Biochem. 1977; 46: 897
        • Hiramatsu K
        • Bierman EL
        • Chait A
        Metabolism of low density lipoprotein from patients with hypertriglyceridemia and diabetes.
        Diabetes. 1985; 34: 8
        • Marklund SL
        • Holme E
        • Hellner L
        Superoxide dismutase in extracellular fluids.
        Clin Chim Acta. 1982; 126: 41
        • Karlsson K
        • Marklund SL
        Extracellular superoxide dismutase by human cell lines.
        Biochem J. 1988; 255: 223
        • Avissar N
        • Whitin JC
        • Allen PZ
        • Palmer IS
        • Cohen HJ
        Antihuman plasma glutathione peroxidase antibodies: immunologic investigations to determine plasma glutathione peroxidase protein and selenium content in plasma.
        Blood. 1989; 73: 318
        • Baader WJ
        • Hatzelmann A
        • Ullrich V
        The suppression of granulocyte functions by lipophilic antioxidants.
        Biochem Pharmacol. 1988; 37: 1089
        • Suarna C
        • Hood RL
        • Dean RT
        • Stocker R
        Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogenous system, and in rat and human lipoproteins.
        Biochim Biophys Acta. 1993; 1166: 163
        • Reaven PD
        • Witztum JL
        Comparison of supplementation of RRR-α-tocopherol and racemic α-tocopherol in humans.
        Arteriosclerosis Thromb. 1993; 13: 601
        • Jialal I
        • Norkus EP
        • Cristol L
        • Grundy SM
        Beta-carotene inhibits the oxidative modification of low-density lipoprotein.
        Biochim Biophys Acta. 1991; 1086: 134
        • Krinsky NI
        Mechanism of action of biological antioxidants.
        in: 2nd Ed. Proc Soc Exp Biol Med. 200. 1992: 248
        • Ringer TV
        • DeLoof MJ
        • Winterrowd GE
        • et al.
        Betacarotene's effects on serum lipoproteins and immunologic indices in humans.
        Am J Clin Nutr. 1991; 53: 688
        • Kardinaal AFM
        • Kok FJ
        • Ringstad J
        • Gomez-Aracena J
        • Mazaev VP
        • Kohlmeier L
        • Martin BC
        • Aro A
        • Kark JD
        • Delgado-Rodriguez M
        • Riemersa RA
        • van't Veer P
        • Huttunen JK
        • Martin-Moreno JM
        Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study.
        Lancet. 1993; 342: 1379
        • Gaziano JM
        • Mason JAE
        • Ridker PM
        • Buring JE
        • Hennekens CH
        Beta carotene therapy for chronic stable angina.
        Circulation. 1990; 82: III-201
        • Princen HMG
        • Van Poppel G
        • Vogelezang C
        • Bluytenhak R
        • Kok FJ
        Supplementation of vitamin E but not β-carotene in vivo protects LDL from lipid peroxidation.
        Arteriosclerosis Thromb. 1992; 12: 554
        • Rimm EB
        • Stampfer MJ
        • Ascherio A
        • Giovannucci E
        • Colditz GA
        • Willett WC
        Vitamin E consumption and the risk of coronary heart disease in men.
        N Engl J Med. 1993; 328: 1450
        • Jialal I
        • Grundy S
        The effect of dietary supplementation with α-tocopherol on the oxidative modification of low density lipoprotein.
        J Lipid Res. 1992; 33: 899
        • Jialal I
        • Grundy SM
        Effect of combined supplementation with α-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation.
        Circulation. 1993; 88: 2780
        • Dieber-Rotheneder M
        • Puhl H
        • Waeg G
        • Striegl G
        • Esterbauer H
        Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation.
        J Lipid Res. 1991; 32: 1325
        • Jessup W
        • Rankin SM
        • De Whalley CV
        • Hoult JRS
        • Scott J
        • Leake DS
        α-Tocopherol consumption during low density lipoprotein.
        Biochem J. 1990; 265: 399
        • Jialal I
        • Grundy SM
        Effect of dietary supplementation with α-tocopherol on the oxidative modification of low density lipoprotein.
        J Lipid Res. 1992; 33: 899
        • Babiy AV
        • Gebicki JM
        • Sullivan DR
        Vitamin E content and low density lipoprotein oxidizability induced by free radicals.
        Atherosclerosis. 1990; 81: 175
        • Eisenberg S
        High density lipoprotein metabolism.
        J Lipid Res. 1984; 26: 1017
        • Parthasarathy S
        • Barnett J
        • Fong LG
        High-density lipoprotein inhibits the oxidative modification of low density lipoprotein.
        Biochim Biophys Acta. 1990; 1044: 275